Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-20
1995-05-16
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514333, 514339, 546201, 546256, 546273, A61K 31445, A61K 3144, C07D40106, C07D40114
Patent
active
054160995
ABSTRACT:
Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the aggregation of blood platelets. wherein G is: ##STR2##
REFERENCES:
patent: 3322631 (1967-05-01), Sprague et al.
patent: 4010274 (1977-03-01), Giraldi et al.
patent: 4122255 (1978-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 4622331 (1986-11-01), Jozic
patent: 5030654 (1991-07-01), Barnish et al.
patent: 5260316 (1993-11-01), Van Duzer et al.
Sugimoto et al. J. Med. Chem. 27(10), (1984), 1300-5.
Birchenough Laura A.
Egbertson Melissa
Hartman George D.
Vassallo Laura M.
DiPrima Joseph F.
Henley III Raymond
Merck & Co. , Inc.
Parr Richard S.
Spivack Phyllis G.
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-637931